ArticleBMC cancer2017

Disruption of TWIST1-RELA binding by mutation and competitive inhibition to validate the TWIST1 WR domain as a therapeutic target.

Cai M Roberts et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.